Skip to content

Extracorporeal cytokine adsorption using CytoSorb® filter for adjuvant therapy of septic shock

Share on facebook
Share on twitter
Share on linkedin

According to the current definition, sepsis is a life-threatening organ dysfunction due to a dysregulated body response to an infection. This systemic infection can be caused by bacteria, fungi or even viruses.

Sepsis has a high mortality rate and is therefore still one of the most frequent causes of death worldwide and in Germany. The diseases increased in Germany from 2007 to 2013 by 5.7% …

About us

Cytosorbents Europe GmbH, headquartered in Berlin, is a wholly owned subsidiary of CytoSorbents Corporation of Monmouth Junction, New Jersey, USA, where the CytoSorb product is manufactured. CytoSorb is the company’s flagship product, backed by more than 30 patent families.

More in the press

Follow us

CytoSorb User´s Meeting

Play Video

Subscribe to our newsletter now!

Get access to the CytoSorbents Community Area. The current newsletter contains a direct link to the CytoSorbents Community Area.